ANDA Suitability for Duloxetine HCI Delayed-Release Capsules, 40 mg - CLOSED | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2010-P-0535

ANDA Suitability for Duloxetine HCI Delayed-Release Capsules, 40 mg - CLOSED

Documents

Comments

Description

CLOSED

Comment Period OpensNov 19, 2010

Type	Title	Posted	Comments	Status
Other	Response Letter from FDA CDER to Hyman, Phelps & McNamara, P.C.	Apr 20, 2026	--

CDER

Duloxetine HCI

Capsules

40 mg

ANDA

CLOSED